DACH venture capital spans three neighboring but distinct startup markets: Germany, Austria and Switzerland. Some managers publish a cross-border mandate, while others target a particular city, country, scientific field or company stage.
Use this guide to compare 19 selected investor and financing routes by geographic mandate, first-investment stage and sector. It is a research shortlist, not a ranking or a promise that every investor accepts companies in all three markets.
Choose a DACH investor route
- Record the company connection. Note registration, founder location and operating markets separately.
- Check the stated geographic mandate. A DACH-focused firm, a European fund and a Swiss-only investor are different fits.
- Match the next milestone. Scientific validation, initial customers and commercial expansion require different evidence.
- Separate instruments and programs. Direct company equity, research commercialization and fund-manager products have different decision makers.
Compare 19 DACH investor routes
Use provider type, stage and geographic connection together. An office address is not a promise of eligibility. Where the current source does not establish a precise entry stage, the table leaves that question open.
Selected DACH-relevant venture and financing routes researched October 29, 2026. A country office or European portfolio does not establish eligibility in all three countries. On small screens, scroll the table sideways to see every column.
| Investor or network | Provider type | Stage | Sector focus | Geographic connection |
|---|---|---|---|---|
| xdeck Venture Fund | Venture fund, distinct from its accelerator | Pre-seed and seed | B2B technology | DACH and Europe |
| b2venture | Venture firm working with an angel community | Earliest stages; follow-on support | Innovative technology | European strategy; Munich and St. Gallen offices |
| Earlybird | Venture firm | Pre-seed to Series A on its current main platform | Emerging technology | European investment focus; Berlin and Munich offices |
| HV Capital | Multi-stage venture firm | Multiple stages | Technology businesses across several sectors | German investment manager; European innovation focus |
| UVC Partners | Technology venture investor | Confirm current entry stage | Industrial and frontier technology; portfolio spans software and research-led companies | Munich ecosystem and wider European company activity |
| Speedinvest | Sector-specialist venture platform | Seed through growth routes on its current site | AI/infrastructure, climate/industrial, deep tech, fintech, health and consumer | Teams across Europe with a Berlin office |
| Founderful | Venture capital firm | First financing round | Technology; Swiss founder teams | Swiss venture firm with a Zurich office |
| Redalpine | Multi-stage venture investment adviser | Multi-stage; confirm relevant vehicle | Software and science | Swiss roots; pan-European approach |
| VI Partners | Venture capital firm | Early-stage | Life sciences and B2B technologies | Switzerland and Europe |
| Verve Ventures | Deep-tech investment platform | Confirm current vehicle and stage | Energy and resources; computing; health and bio | Swiss-operated platform focused on European deep tech |
| Spicehaus Partners | Venture capital firm | Early-stage; first revenues toward scale | B2B technology with technical differentiation | Companies headquartered in Switzerland |
| 3VC | European technology venture firm | Confirm current entry stage; seeks initial product-market evidence | Technology | European startups; Austrian connection in established Vienna research |
| aws Gründungsfonds | Austrian venture fund | Confirm current vehicle and stage | Technology with growth potential | Austria-connected venture route |
| XISTA science ventures | Research-linked venture investor | Early science-to-venture investment | Scientific and deep technology | Anchored at the Institute of Science and Technology Austria |
| APEX Ventures | Specialist venture firm | Seed to Series A | Deep tech; AI; energy; medical technology; space | European investment remit; Austria-connected research |
| tecnet equity | Technology-transfer and venture investor | Confirm current route and entry stage | Technology transfer and venture companies | Austria-connected technology commercialization |
| Calm/Storm | Health-technology venture firm | Very early; often first round | Health technology | European health technology; Austria-connected research |
| Elevator Ventures | Corporate-backed venture investor | Early stage | Fintech and beyond banking | Companies in DACH and Central/Eastern Europe |
| PUSH VC | Specialist early-stage venture firm | Pre-seed and seed; follow-ons differ | Health and climate-related technology | Europe, especially Austria and Germany |
Separate national routes from cross-border funds
Elevator Ventures explicitly names DACH and Central/Eastern Europe among its geographies, and xdeck describes DACH and European technology investment. Founderful and Spicehaus describe Swiss connections more specifically. A founder should record the published mandate rather than assuming that every local office invests everywhere in the region.
Country-focused resources remain useful for local context. This regional guide helps a company compare which mandate and vehicle to research across the three markets.
Research-led and industrial teams need different proof
XISTA combines research commercialization support with a distinct venture-investment route. APEX focuses on early technical companies, and UVC describes industrial and frontier technology. For a research-origin company, state the validated result, outstanding engineering risk, product path and prospective buyer.
An affiliation with a university or technical institute is a useful signal to investigate, not a funding decision or evidence that every fund has an open allocation.
Use a specialist thesis as a filter
Calm/Storm describes a health-technology focus; VI Partners has life-science and B2B technology strategies. Elevator Ventures names fintech and related banking technology. A founder should match the actual customer problem and product evidence to a team's current thesis, not select a firm only because its office is nearby.
Make a defensible cross-border shortlist
For each candidate, retain the official strategy source, date, relevant vehicle, country scope, entry stage and a specific next question. Check whether a founder route is open and whether a company must meet a local registration or operating requirement. A portfolio logo is evidence of a past investment, not a guarantee for the next applicant.
Investor profiles and official routes
These profiles are a research aid, not a performance ranking. Read the current strategy and portfolio before sharing a deck. A public contact route does not establish that a firm has available allocation for your round.
xdeck Venture Fund
Venture fund, distinct from its accelerator. DACH and Europe. Count the venture fund once. The separately described no-equity accelerator explicitly offers no investment and is not another investor.
xdeck Venture Fund: official investment information · Contact
b2venture
Venture firm working with an angel community. European strategy; Munich and St. Gallen offices. A venture-fund decision and an individual angel's decision are not interchangeable. Identify the route you are approaching.
b2venture: official investment information · Contact
Earlybird
Venture firm. European investment focus; Berlin and Munich offices. Earlybird and Earlybird Venture Capital are one entry, not two offices counted twice. Check separate specialist vehicles where relevant.
Earlybird: official investment information · Contact us
HV Capital
Multi-stage venture firm. German investment manager; European innovation focus. Use the current approach and the responsible team to establish fit; a large multi-stage platform does not make every round eligible.
HV Capital: official investment information · Additional official strategy or location evidence
UVC Partners
Technology venture investor. Munich ecosystem and wider European company activity. Bring technical milestones and commercialization evidence. Do not infer your eligible financing stage solely from a portfolio company's later round.
UVC Partners: official investment information · Contact us · Additional official strategy or location evidence
Speedinvest
Sector-specialist venture platform. Teams across Europe with a Berlin office. Select the relevant sector team and financing stage. Do not preserve an outdated pre-seed-to-Series-A-only description.
Speedinvest: official investment information · Additional official strategy or location evidence
Founderful
Venture capital firm. Swiss venture firm with a Zurich office. Its current proposition is to lead a founder team's first financing round. Compare that earliest-stage role with the later commercialization evidence a specialist may want; its campus activities are not a second fund to count.
Founderful: official investment information
Redalpine
Multi-stage venture investment adviser. Swiss roots; pan-European approach. The current site calls Redalpine an investment adviser and emphasizes the intersection of software and science. Ask which advised vehicle and team match the company's stage rather than treating every portfolio company as a current mandate.
Redalpine: official investment information · contact
VI Partners
Venture capital firm. Switzerland and Europe. Its current About and Contact pages state an early-stage technology and healthcare focus across Switzerland and Europe. Match the company's evidence to the appropriate life-sciences or B2B team before requesting a conversation.
VI Partners: official investment information · Published founder contact guidance · Additional official strategy or location evidence
Verve Ventures
Deep-tech investment platform. Swiss-operated platform focused on European deep tech. Use the current three investment topics to identify the relevant team. The website's investor Apply button is not established here as a founder pitch form, so begin with the official investment information rather than joining an investor onboarding flow.
Verve Ventures: official investment information · Current investment topics and team · Additional official strategy or location evidence
Spicehaus Partners
Venture capital firm. Companies headquartered in Switzerland. Its current website calls for must-have B2B technology and a Swiss headquarters. Record the customer evidence and operating connection explicitly; an overseas sales office does not establish the headquarters condition.
Spicehaus Partners: official investment information · Submit your pitch
3VC
European technology venture firm. European startups; Austrian connection in established Vienna research. Its current approach highlights European technology companies with signs of customer demand. Verify the company and current fund's criteria directly.
3VC: official investment information · Contact
aws Gründungsfonds
Austrian venture fund. Austria-connected venture route. The manager describes venture capital for high-growth technology companies. Confirm the relevant current vehicle and founder process.
aws Gründungsfonds: official investment information
XISTA science ventures
Research-linked venture investor. Anchored at the Institute of Science and Technology Austria. Separate the research and incubation offering from the actual venture investment decision. Explain technical validation and the business path.
XISTA science ventures: official investment information
APEX Ventures
Specialist venture firm. European investment remit; Austria-connected research. Match the technical depth and current European mandate. An office connection alone does not establish country eligibility.
APEX Ventures: official investment information · Get in touch
tecnet equity
Technology-transfer and venture investor. Austria-connected technology commercialization. The official site distinguishes venture investment and technology transfer. Identify the relevant team and process for the company.
tecnet equity: official investment information
Calm/Storm
Health-technology venture firm. European health technology; Austria-connected research. The published thesis is specific to health technology and very early founders. Ask about the actual current geographic and vehicle fit.
Calm/Storm: official investment information · Submit your pitch
Elevator Ventures
Corporate-backed venture investor. Companies in DACH and Central/Eastern Europe. The published geography and fintech focus are distinct from the separate fund-of-funds activity. Use the company investment route.
Elevator Ventures: official investment information · Contact us
PUSH VC
Specialist early-stage venture firm. Europe, especially Austria and Germany. Show how the company fits the health or planetary thesis, then confirm the investment vehicle and current process.
PUSH VC: official investment information
A worked shortlist for a DACH research spinout
Illustrative example, not an investment recommendation. A Vienna research team has a prototype sensor and a Swiss pilot partner. It needs financing to validate manufacturing and customer adoption. The facts are invented and no listed provider has evaluated the company.
Research questions for the fictional team
| Route | Why research it | Question to verify |
|---|---|---|
| XISTA science ventures | Science-to-venture activity | Does the current investment process fit the team's research connection? |
| APEX Ventures | Early deep-tech thesis | Is the sensor's technical differentiation and stage appropriate? |
| UVC Partners | Industrial and frontier technology | Does the commercial deployment case meet the current thesis? |
| Founderful | Swiss founder-team focus | Does a Swiss pilot partner meet any actual company or founder criteria? |
| Elevator Ventures | Published DACH remit | Is the product genuinely within its fintech or banking-related focus? |
The last two questions may lead to a hold rather than an outreach action. No match should be assumed.
Copy your DACH investor shortlist worksheet
Use one record for each investor and specific vehicle. Keep the source date beside your fit decision.
DACH INVESTOR FIT CARD
Company registration and founder location: [facts]
Product, buyer and next milestone: [facts]
Current proof: [research / prototype / pilot / revenue]
Investor and actual vehicle: [name]
Official mandate and source date: [source]
Germany / Austria / Switzerland connection: [published scope; question]
Entry stage and sector: [evidence]
Instrument and decision maker: [company investment / program / other]
Missing evidence: [what must be confirmed]
Next research action and owner: [action; date]Research the shortlist with Aurora, Claude or Codex
Give your AI teammate company facts you are authorized to share. Ask for sourced comparisons and open questions, not automatic introductions or outreach.
Be my DACH-focused investor-research teammate.
Company: [product, buyer and facts I may share]
Company registration, founders and operating markets: [facts]
Current proof and next financing milestone: [facts]
Candidate investors and vehicles: [names]
Use current official sources to compare geography, entry stage and thesis.
Separate DACH-wide mandates from country-specific company requirements.
Distinguish direct investment, research programs and fund-manager products.
Deduplicate offices, affiliated programs and fund names.
Return source/date, supported fit, unresolved questions and a next research action.
Do not invent eligibility, allocations, check sizes or introductions.
Do not contact anyone or provide personalized legal, tax or financial advice.Keep the resulting investor records, relationship context and next actions together in Finta. The investor-prospecting workflow covers the next execution step.
Methodology, research date and local guides
Research checked October 29, 2026 by the Finta Editorial Team with AI-assisted source review. We reconciled provider names from our existing city research and reviewed current official strategy, portfolio, location or founder-contact pages. Firms with multiple offices count once; angel networks count as networks, not one committed pooled fund. We distinguish local presence from investment mandate and company eligibility. We do not infer check sizes, investor returns, lead behavior or open allocation from a portfolio logo.
We reused current provider-level evidence from established German, Austrian and Swiss city research and added a regional comparison. Country-specific and pan-European investment mandates are identified separately. Managers with several offices or related fund products count once.
This is a selected directory, not an exhaustive register or a funding recommendation. Current strategy, available allocation and eligibility should be checked with the responsible team.
Informational purposes only. Finta is not a law firm or accounting firm. This is general fundraising information, not personalized financial, legal or tax advice. Discuss financing instruments, company structures and tax consequences with your attorney or accountant.
This is a selected research directory, not an exhaustive register or sponsored ranking. Confirm the current vehicle, team and process directly before relying on a fit decision.
- nrw venture capital investors
- zurich vc firms angel investors
- frankfurt hessen startup investors
- munich venture capital investors
- austria vienna venture capital investors
- lausanne western switzerland startup investors
- berlin vc firms angel investors
Make the next fundraising step specific
Choose a small set of defensible matches, record the open question, and assign the next action. Use our investor-shortlist guide and warm-introduction guide to prepare the conversation. A longer list should make the research better, not turn into an indiscriminate mailing list.